Powers Advisory Group’s GSK GSK Stock Holding History

Powers Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$226K	Sell	4,686 -114	-2%	-$5.82K	0.07%	122
2026 Q2	$252K	Sell	4,800 -384	-7%	-$20.3K	0.08%	123
2026 Q1	$286K	Buy	5,184 +1	+0%	+$54	0.1%	107
2025 Q4	$254K	Buy	5,183 +1	+0%	+$47	0.1%	112
2025 Q3	$224K	Buy	+5,182	New	+$202K	0.09%	116
2024 Q2	–	Sell	-4,850	Closed	-$208K	–	97
2024 Q1	$208K	Sell	4,850 -1,081	-18%	-$44.6K	0.12%	93
2023 Q4	$220K	Sell	5,931 -295	-5%	-$10.6K	0.14%	90
2023 Q3	$226K	Hold	6,226	–	–	0.15%	84
2023 Q2	$222K	Sell	6,226 -321	-5%	-$11.5K	0.15%	87
2023 Q1	$233K	Hold	6,547	–	–	0.16%	88
2022 Q4	$230K	Buy	+6,547	New	+$218K	0.17%	85
2022 Q3	–	Sell	-7,015	Closed	-$382K	–	93
2022 Q2	$382K	Sell	7,015 -291	-4%	-$16.1K	0.29%	69
2022 Q1	$398K	Buy	7,306 +51	+0.7%	+$2.77K	0.28%	72
2021 Q4	$400K	Buy	+7,255	New	+$377K	0.28%	70

Other funds holding GSK

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Keating Investment Counselors Delray Beach, Florida $382M AUM 16.71% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Gilman Hill Asset Management New Canaan, Connecticut $718M AUM 15.3% 1-Year Est. Return

Powers Advisory Group's GSK Position: Q3 2026 in Review

Powers Advisory Group reduced its GSK (GSK) stake by 2.4% in Q3 2026, selling an estimated $5.82K and leaving 4,686 shares worth $226K. The position accounts for 0.07% of the portfolio, ranked #122.

Powers Advisory Group first reported a position in GSK in Q4 2021 and has held it in 14 quarters since. The position peaked at $400K in Q4 2021. 209 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Powers Advisory Group held 4,686 shares of GSK worth $226K as of Q3 2026.
Powers Advisory Group sold 114 GSK shares in Q3 2026, an estimated $5.82K.
GSK made up 0.07% of Powers Advisory Group's portfolio in Q3 2026, its #122 holding.
Powers Advisory Group first reported a position in GSK in Q4 2021 and has held it in 14 quarters since.
Powers Advisory Group's GSK position peaked at $400K in Q4 2021.
209 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Powers Advisory Group's 13F filing for Q3 2026, filed 14 Oct 2026.